financetom
Business
financetom
/
Business
/
Mannatech Names James Clavijo Finance Chief
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mannatech Names James Clavijo Finance Chief
Jul 2, 2024 1:46 AM

04:18 AM EDT, 07/02/2024 (MT Newswires) -- Mannatech ( MTEX ) said Monday it has named James Clavijo as chief financial officer, effective immediately.

Clavijo, who has more than 25 years of experience, previously served as CFO of Longeveron (LVGN)and Aeterna Zentaris ( AEZS ) .

Chief Executive Landen Fredrick, who has been serving as interim CFO since January, will relinquish his responsibilities to Clavijo, the health and wellness company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Metro Renewing Its Share Buyback Program
Metro Renewing Its Share Buyback Program
Nov 25, 2025
08:52 AM EST, 11/25/2025 (MT Newswires) -- METRO INC. ( MTRAF ) , a food and pharmacy player in Quebec and Ontario, announced Tuesday that it is renewing its normal course issuer bid program and that such renewal has been approved by the Toronto Stock Exchange. In a statement the corporation said it decided to renew the issuer bid program...
Max Power Completes Drilling Into Canada's First-Ever Natural Hydrogen Well
Max Power Completes Drilling Into Canada's First-Ever Natural Hydrogen Well
Nov 25, 2025
08:54 AM EST, 11/25/2025 (MT Newswires) -- Max Power Mining ( MAXXF ) said Tuesday that it completed drilling into Canada's first-ever well targeting natural hydrogen, reaching a total depth of 2,278 meters at the Lawson target on the Genesis trend. Max Power said the successful test of concept has triggered extensive data analysis to confirm concentrations of natural hydrogen...
Teva Pharmaceutical Says Denosumab Biosimilars Get European Commission Marketing Approval
Teva Pharmaceutical Says Denosumab Biosimilars Get European Commission Marketing Approval
Nov 25, 2025
08:54 AM EST, 11/25/2025 (MT Newswires) -- Teva Pharmaceutical Industries ( TEVA ) subsidiary Teva Pharmaceuticals International said Tuesday that it received marketing authorizations from the European Commission for two denosumab biosimilar candidates. The company said the authorizations were granted for Ponlimsi and Degevma, biosimilars to Amgen's ( AMGN ) Prolia and Xgeva, respectively. Ponlimsi is indicated for the treatment...
Sector Update: Consumer
Sector Update: Consumer
Nov 25, 2025
08:55 AM EST, 11/25/2025 (MT Newswires) -- Consumer stocks were steady premarket Tuesday, with the Consumer Staples Select Sector SPDR Fund (XLP) inactive and the Consumer Discretionary Select Sector SPDR Fund (XLY) slightly advancing. Alibaba Group Holding ( BABA ) stock was up more than 2% after the company posted higher fiscal Q2 revenue that also exceeded market expectations. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved